Table 1.

Characteristics of the patients enrolled (n = 22)

Age (year)	35·4 ± 11·4 (19–55)
Disease duration (month)	98·8 ± 79·6 (9–276)
Menopause	2 (9·1%)
Hormone replacement therapy	0
Oral contraceptives	0
SLEDAI	4·6 ± 6·0 (0–22)
≥4 (active)	10 (45·5%)
<4	12 (54·5%)
C3 (mg/dl)	87·6 ± 33·6
C4 (mg/dl)	14·5 ± 7·2
Prednisolone dose (mg/day)	9·65 ± 9·62 (0-35)
Other immunosuppressants
Hydroxychloroquine	12 (54·5%)
Mycophenolate	5 (27·8%)
Mizoribine	2 (9·1%)
Azathioprine	2 (9·1%)

SLEDAI, SLE disease activity index.